SPOTLIGHT -
Dr. Kaubisch on the REACH Trials in HCC
Andreas Kaubisch, MD, discusses the phase III REACH and REACH-2 trials in advanced hepatocellular carcinoma.
Read More
Dr. Kaubisch on Treatment Options for HCC
Andreas Kaubisch, MD, discusses available treatment options for hepatocellular carcinoma.
Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL
Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
Better Understanding of Biomarkers Can Inform Immunotherapy Treatment in SCLC